22 May 2013
Keywords: debiopharm, exercises, option, ad, drug, switzerland, exercised
Article | 24 May 2004
Switzerland's Debiopharm has exercised its option right by signing a licensing agreement with the Shanghai Institute of Materia Medica,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
21 May 2013
© 2013 thepharmaletter.com